UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000023276 |
|---|---|
| Receipt number | R000026649 |
| Scientific Title | Phase I trial of the Toll-like receptor 9 agonist CpG-ODN(K3) as immunotherapy for patients with recurrent/metastatic lung cancer |
| Date of disclosure of the study information | 2016/09/01 |
| Last modified on | 2023/07/02 15:38:25 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/07/21 13:46:35 | ||
| 2 | Update | 2017/01/23 10:33:37 | Recruitment status |
|
| 3 | Update | 2017/12/21 14:13:05 | Division name Division name Last name of contact person Last name of contact person Division name Division name Homepage URL Organization Organization Division name Division name Address Address TEL Institute Department |
|
| 4 | Update | 2018/05/29 13:02:53 | Anticipated trial start date |
|
| 5 | Update | 2018/05/29 13:05:09 | Last name of contact person Last name of contact person TEL |
|
| 6 | Update | 2019/07/17 18:05:23 | Recruitment status Date of IRB Last follow-up date |
|
| 7 | Update | 2023/07/02 14:33:50 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 8 | Update | 2023/07/02 15:38:25 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
